Medications designed to block a signaling protein called NOTCH3 — which plays a key role in the function and survival of cells in the body…
Myeloma
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Latest news
Discussion
I’m writing this a few days after the end of ASH 2025, the annual meeting of the American Society of Hematology. As I mentioned…
VV169, an experimental cellular therapy being developed by Vyriad to treat myeloma, is expected to enter clinical testing in 2026, the…
Discussion
This morning, while I was making myself a cup of coffee, I saw my reflection in the curved, stainless steel surface of the kettle as…
Johnson & Johnson (J&J) is asking the U.S. Food and Drug Administration (FDA) to approve a combination of two medications, Tecvayli (teclistamab) and…
Discussion
A caregiver’s energy is a rare currency. When we spend it, we’re not doing so in single, large transactions. Instead, we’re making thousands of tiny…
